This patent covers the expansion of hematopoietic stem cells, both in vitro and in vivo with fibroblast growth factors. This patent is important not only for stimulation of post-ablation hematopoiesis, but can also be used to cover angiogenesis stimulation by fibroblast growth factors since angiogenesis involves hematopoietic stem cells, at least in some embodiments.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.